Abstracts

677 – Hypertension Risk in a Large Cohort of People Living With HIV After a Switch to Dolutegravir

Background Dolutegravir (DTG) and other integrase inhibitors have been associated with an increased risk of hypertension (HTN); however, the data are conflicting and limited from low- and middle-income countries (LMICs). The weight gain threshold associated with HTN risk is also unclear, with prior studies using increases of ≥5% or ≥10%. We evaluated the association between…

689 – Weight Change Under Dual Without Tenofovir vs Triple Therapy: Week 96 MODERATO Trial ANRS-MIE 12372

Background Dual therapies, particularly the DTG/3TC combination, are now recommended by the WHO as an alternative to TDF-based triple ART for virologically controlled patients. We have worked on the issue of weight gain under dual therapy in sub-Saharan Africa. Methods We conducted a study in three subsaharian Africa countries, randomizing HIV-1 adults on TDF+3TC+EFV (TLE) for…

736 – Ageing and Hypertension, but Not HIV, Predict Kidney Dysfunction in Older Adults in Urban Tanzania

Background Adults living with HIV have more than a threefold increased risk of developing kidney disease compared to those without HIV. However, the risk among ageing populations with HIV, specifically where risk factors such as hypertension and diabetes are more prevalent, is not well understood. We compared HIV-positive and HIV-negative older adults to determine whether kidney…

747 – Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID

Background Long COVID (LC) affects at least 5% of individuals following acute SARS-CoV-2 infection, translating to more than 400 million cases globally. Among the proposed mechanisms underlying LC pathogenesis, viral persistence has garnered increasing attention. Persistent detection of SARS-CoV-2 antigens in plasma has been reported up to 12 months post-infection, suggesting ongoing viral activity or…

500 – Mpox Seropositivity in a Cohort of Males With Sexual Risk Factors in the Philippines

Background Recent global mpox outbreaks have caused significant morbidity and burdened healthcare systems. Asymptomatic cases have been reported, particularly in Southeast Asia, and may have fueled sexual transmission before mpox was detected by public health systems. We used banked blood samples to evaluate possible sub-clinical circulation of mpox via serologic testing among men who have sex with…

545 – First Antiviral Regimen and Modification Patterns in People Who Recently Acquired HIV

Background Modern antiretrovirals are highly efficacious, however modification of antiretroviral therapy (ART) is still required due to adverse effects, simplification, safety and/or loss of virological control. We examined time to first ART modification (including predictors and modification type) in individuals diagnosed within 12 months of HIV acquisition. Methods We pooled data from the CASCADE Study,…

283 – Post-Hoc Comparison of AS01B, MF59, and Alum Adjuvants Across 4 HIV Vaccine Trials

Background Vaccine adjuvants enhance humoral and cellular responses but may induce reactogenicity. AS01B, MF59, and Alum have distinct mechanisms, yet head-to-head comparisons of immunogenicity and reactogenicity are scarce. Methods We conducted a cross-protocol, post-hoc, analysis of four randomized, controlled, double-blind trials (HVTN 100, 107, 120, and 702) of adults without HIV who received ALVAC-HIV (vCP2438)…

622 – Mortality for Cancer in PWH Compared to the General Population: Data From ICONA Cohort, 2006-2023

Background Malignancies represent a persistent burden of morbidity and mortality in people with HIV (PWH). The study aimed to compare cancer-related mortality in PWH with the Italian general population. Methods All antiretroviral naïve PWH enrolled in the ICONA cohort (2006-2023) were included. Demographic and clinical characteristics were collected from ICONA database. Deaths caused by cancer (virus-related and…

1085 – PEPFAR-Supported Sites in Sub-Saharan Africa Exposed to Conflict in 2024

Background Sub-Saharan African countries supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) frequently experience conflict events such as battles, explosions, riots, and violence against civilians. These events can disrupt the continuity of antiretroviral therapy (ART) treatment for people living with HIV. Understanding the scope of conflict exposure on PEPFAR-supported sites and their beneficiaries is…

1100 – Advancing the 3rd “95”: Evidence From DSD and Multimonth Dispensing Models in Kampala, Uganda

Background Differentiated service delivery models (DSDM) for antiretroviral therapy (ART), including multi-month dispensing (MMD), have been scaled up to improve treatment outcomes and reduce the burden on HIV care programs. However, evidence on their contribution to sustained virological suppression (3rd 95) within Ugandan programmatic settings remains limited. We examined the contribution of DSDM and MMD…